These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30 related articles for article (PubMed ID: 3613634)
21. The effect of phospholipase inhibitor mepacrine on platelet aggregation, the platelet release reaction and fibrinogen binding to the platelet surface. Winocour PD; Kinlough-Rathbone RL; Mustard JF Thromb Haemost; 1981 Jun; 45(3):257-62. PubMed ID: 7281105 [TBL] [Abstract][Full Text] [Related]
22. Cerebroprotective action of the phospholipase inhibitor quinacrine in the ischemia/reperfused gerbil hippocampus. Phillis JW Life Sci; 1996; 58(6):PL97-101. PubMed ID: 8569417 [TBL] [Abstract][Full Text] [Related]
23. Inhibition of complement-mediated hepatic thromboxane production by mepacrine, a phospholipase inhibitor. Flynn JT Prostaglandins; 1987 Feb; 33(2):287-99. PubMed ID: 3296007 [TBL] [Abstract][Full Text] [Related]
24. Mepacrine, a phospholipase inhibitor. A potential tool for modifying myocardial reperfusion injury. Otani H; Engelman RM; Breyer RH; Rousou JA; Lemeshow S; Das DK J Thorac Cardiovasc Surg; 1986 Aug; 92(2):247-54. PubMed ID: 3736082 [TBL] [Abstract][Full Text] [Related]
25. Mepacrine, a phospholipase inhibitor. Seguin J; Berta P; Saussine M; Chaptal PA J Thorac Cardiovasc Surg; 1987 Aug; 94(2):312-4. PubMed ID: 3613634 [No Abstract] [Full Text] [Related]